Diagnosis and clinical management of neurological disorders caused by cytomegalovirus in AIDS patients

被引:38
作者
Cinque, P
Cleator, GM
Weber, T
Monteyne, P
Sindic, C
Gerna, G
van Loon, AM
Klapper, PE
机构
[1] Univ Milan, Osped San Raffaele, I-20127 Milan, Italy
[2] Univ Manchester, Dept Pathol Sci, Manchester, Lancs, England
[3] Marien Hosp, Hamburg, Germany
[4] Catholic Univ Louvain, Brussels, Belgium
[5] Policlin San Matteo, IRCCS, I-27100 Pavia, Italy
[6] Acad Hosp Utrecht, Utrecht, Netherlands
关键词
CMV encephalitis; nervous system; PCR; ganciclovir; foscarnet;
D O I
10.3109/13550289809113490
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cytomegalovirus (CMV) infections are common and severe complications of HIV infection. The virus involves the nervous system, causing encephalitis, polyradiculomyelitis and peripheral neuropathies, Due to their limited sensitivity, traditional virological approaches, such as virus isolation or antigen detection in the CSF are useful only in limited instances, e.g. CMV polyradiculopathy. The aetiological diagnosis of these disorders relies on the analysis of cerebrospinal fluid by PCR and quantitative PCR may be important to establish the extent of CNS lesions and to monitor the efficacy of antiviral treatments, CMV is susceptible to various antivirals, including ganciclovir, foscarnet and cidofovir. CMV infections of the nervous system, in particular encephalitis, however, show only a poor response to standard treatments, Drug combination treatments i.e. ganciclovir plus foscarnet, are currently under evaluation in clinical trials.
引用
收藏
页码:120 / 132
页数:13
相关论文
共 115 条
  • [41] GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS
    EBRIGHT, JR
    CRANE, LR
    [J]. AIDS, 1991, 5 (05) : 604 - 604
  • [42] GANCICLOVIR FOSCARNET FOR CYTOMEGALOVIRUS MENINGOENCEPHALITIS IN AIDS
    ENTING, R
    DEGANS, J
    REISS, P
    JANSEN, C
    PORTEGIES, P
    [J]. LANCET, 1992, 340 (8818) : 559 - 560
  • [43] FIALA M, 1988, REV INFECT DIS, V10, P250
  • [44] (+/-)-(1-ALPHA,2-BETA,3-ALPHA)-9-[2,3-BIS(HYDROXYMETHYL)-CYCLOBUTYL]GUANINE [(+/-)-BHCG OR SQ 33054] - A POTENT AND SELECTIVE INHIBITOR OF HERPESVIRUSES
    FIELD, AK
    TUOMARI, AV
    MCGEEVERRUBIN, B
    TERRY, BJ
    MAZINA, KE
    HAFFEY, ML
    HAGEN, ME
    CLARK, JM
    BRAITMAN, A
    SLUSARCHYK, WA
    YOUNG, MG
    ZAHLER, R
    [J]. ANTIVIRAL RESEARCH, 1990, 13 (01) : 41 - 52
  • [45] FILLET AM, 1993, AIDS, V7, P1016, DOI 10.1097/00002030-199307000-00018
  • [46] HUMAN PHARMACOKINETICS OF THE ANTIVIRAL DRUG DHPG
    FLETCHER, C
    SAWCHUK, R
    CHINNOCK, B
    DEMIRANDA, P
    BALFOUR, HH
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 40 (03) : 281 - 286
  • [47] DETECTION OF HERPESVIRUS DNA BY NESTED POLYMERASE CHITIN REACTION IN CEREBROSPINAL-FLUID OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS WITH NEUROLOGIC DISEASE - A PROSPECTIVE EVALUATION
    FOX, JD
    BRINK, NS
    ZUCKERMAN, MA
    NEILD, P
    GAZZARD, BG
    TEDDER, RS
    MILLER, RF
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (04): : 1087 - 1090
  • [48] INCREASED EFFICACY OF GANCICLOVIR IN COMBINATION WITH FOSCARNET AGAINST CYTOMEGALOVIRUS AND HERPES-SIMPLEX VIRUS TYPE-2 INVITRO AND INVIVO
    FREITAS, VR
    FRASERSMITH, EB
    MATTHEWS, TR
    [J]. ANTIVIRAL RESEARCH, 1989, 12 (04) : 205 - 212
  • [49] NATURE AND INCIDENCE OF PERIPHERAL-NERVE SYNDROMES IN HIV-INFECTION
    FULLER, GN
    JACOBS, JM
    GUILOFF, RJ
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1993, 56 (04) : 372 - 381
  • [50] FULLER GN, 1989, LANCET, V2, P937